This site is intended only for healthcare professionals resident in the United Kingdom
Prescribing information and adverse event reporting can be found at the bottom or to the right of this page
Downloadthe HCP dosing summary which is a guide to treatment with MYLOTARGTM. The information provided in this document is intended to serve as a convenient reference; SmPC should be consulted for full guidance.
MYLOTARG™ (gemtuzumab ozogamicin) 5 mg powder for concentrate for solution for infusion
Legal category: Prescription only medicine. Cost: £6,300 per vial. Click here to access the MYLOTARG Summary of Product Characteristics hosted on Datapharm’s ‘electronic Medicines Compendium’.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the SmPC for how to report adverse reactions.
Cytarabine 20 mg/mL and 100 mg/mL solution for infusion or injection
Legal category: Prescription only medicine. Basic NHS price: Cytarabine 100 mg/mL, supplied as single vials containing 100 mg/mL cytarabine in 10 mL (1 g), £39.00 or 20 mL (2 g), £77.50. Cytarabine 20 mg/mL supplied as vials containing 20 mg/mL cytarabine in 5 mL (100 mg) in packs of 5, £20.48 or 25 mL (500 mg) as single vials, £19.50.
Click to access the cytarabine 20 mg/mL and 100 mg/mL Summary of Product Characteristics hosted on Datapharm’s ‘electronic Medicines Compendium’.